Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Molecular Immunology|December 17, 2013
The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitisYing Ju, Xuming Shang, Zhanfeng Liu, et al.
Oncotarget|September 6, 2015
Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathwaysLi Yang, Yixuan Hou, Jie Yuan, et al.
Stem Cells (Dayton, Ohio)|September 30, 2015
LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling PathwayMingli Zhou, Yixuan Hou, Guanglun Yang, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 2, 2025
A Synergistic 3D-Printed Collar Transforms Radiofrequency Ablation Into Potent Thermal Immunotherapy for Lung CancerWeiyu Chen, Yuan Wu, Jianhua Luo, et al.
Brain and Behavior|April 3, 2020
Novel and de novo point and large microdeletion mutation in PRRT2-related epilepsyLi Yang, Cuiping You, Shiyan Qiu, et al.
Cell Death & Disease|February 22, 2023
TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axisYuzhen Wang, Yingchun Wang, Wen Liu, et al.
Cell Death & Disease|March 3, 2017
Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancerLiyun Xu, Yixuan Hou, Gang Tu, et al.
Cell Cycle (Georgetown, Tex.)|May 14, 2015
Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-β-catenin signaling pathwaysShifu Tang, Yixuan Hou, Hailong Zhang, et al.
Virus Research|February 17, 2022
Systematic profiling of antigen bias in humoral response against SARS-CoV-2Nana Wei, Qiujing Wang, Zhibing Lin, et al.
Cell Reports. Medicine|August 21, 2024
Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8<sup>+</sup> T cell exhaustion and anti-PD-1 resistanceChaojia Chen, Fangcheng Zhao, Jiali Peng, et al.
Pageof 9